Steris Plc Stock Working Capital
| STE Stock | USD 221.19 1.08 0.49% |
STERIS plc fundamentals help investors to digest information that contributes to STERIS Plc's financial success or failures. It also enables traders to predict the movement of STERIS Stock. The fundamental analysis module provides a way to measure STERIS Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to STERIS Plc stock.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 1.9 B | 1 B | |
| Change In Working Capital | -146.1 M | -138.8 M |
STERIS | Working Capital |
STERIS plc Company Working Capital Analysis
STERIS Plc's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current STERIS Plc Working Capital | 1.94 B |
Most of STERIS Plc's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, STERIS plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
STERIS Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for STERIS Plc is extremely important. It helps to project a fair market value of STERIS Stock properly, considering its historical fundamentals such as Working Capital. Since STERIS Plc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of STERIS Plc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of STERIS Plc's interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Based on the company's disclosures, STERIS plc has a Working Capital of 1.94 B. This is 355.3% higher than that of the Health Care Equipment & Supplies sector and 42.4% higher than that of the Health Care industry. The working capital for all United States stocks is 31.11% lower than that of the firm.
STERIS Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses STERIS Plc's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of STERIS Plc could also be used in its relative valuation, which is a method of valuing STERIS Plc by comparing valuation metrics of similar companies.STERIS Plc is currently under evaluation in working capital category among its peers.
STERIS Plc ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, STERIS Plc's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to STERIS Plc's managers, analysts, and investors.Environmental | Governance | Social |
STERIS Fundamentals
| Return On Equity | 0.0927 | ||||
| Return On Asset | 0.0545 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 24.06 B | ||||
| Shares Outstanding | 98.71 M | ||||
| Shares Owned By Insiders | 0.29 % | ||||
| Shares Owned By Institutions | 99.81 % | ||||
| Number Of Shares Shorted | 1.03 M | ||||
| Price To Earning | 36.93 X | ||||
| Price To Book | 3.33 X | ||||
| Price To Sales | 4.10 X | ||||
| Revenue | 5.14 B | ||||
| Gross Profit | 2.16 B | ||||
| EBITDA | 1.41 B | ||||
| Net Income | 380.08 M | ||||
| Cash And Equivalents | 208.36 M | ||||
| Cash Per Share | 3.16 X | ||||
| Total Debt | 3.38 B | ||||
| Debt To Equity | 0.49 % | ||||
| Current Ratio | 2.03 X | ||||
| Book Value Per Share | 66.80 X | ||||
| Cash Flow From Operations | 973.27 M | ||||
| Short Ratio | 2.10 X | ||||
| Earnings Per Share | 5.93 X | ||||
| Price To Earnings To Growth | 1.29 X | ||||
| Target Price | 249.39 | ||||
| Number Of Employees | 18 K | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 21.83 B | ||||
| Total Asset | 11.06 B | ||||
| Retained Earnings | 2.09 B | ||||
| Working Capital | 1.94 B | ||||
| Current Asset | 972.52 M | ||||
| Current Liabilities | 400.61 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.96 % | ||||
| Net Asset | 11.06 B | ||||
| Last Dividend Paid | 2.13 |
About STERIS Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze STERIS plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STERIS Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STERIS plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether STERIS plc is a strong investment it is important to analyze STERIS Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact STERIS Plc's future performance. For an informed investment choice regarding STERIS Stock, refer to the following important reports:Check out STERIS Plc Piotroski F Score and STERIS Plc Altman Z Score analysis. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.305 | Dividend Share 2.13 | Earnings Share 5.93 | Revenue Per Share 53.903 | Quarterly Revenue Growth 0.073 |
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.